Previous 10 | Next 10 |
home / stock / ipatf / ipatf news
ImmunoPrecise Announces Annual General Meeting Results Canada NewsWire VICTORIA, Dec. 2, 2019 VICTORIA , Dec. 2, 2019 /CNW/ - IMMUNOPRECISE ANTIBODIES LTD. (the "Company" or "IPA") (TSX VENTURE: IPA) (OTC QB: IPATF) announces that all resolutions were passed by the s...
Talem Therapeutics accesses the OmniAb® platform from Ligand Pharmaceuticals Canada NewsWire VICTORIA, Nov. 5, 2019 VICTORIA , Nov. 5, 2019 /CNW/ - IMMUNOPRECISE ANTIBODIES LTD. (the "Company" or "IPA") (TSX VENTURE: IPA) (OTCQB: IPATF), an industry leader in th...
ImmunoPrecise Adopts Shareholder Rights Plan Canada NewsWire VICTORIA, Oct. 18, 2019 VICTORIA , Oct. 18, 2019 /CNW/ - IMMUNOPRECISE ANTIBODIES LTD. (the "Company" or "IPA") (TSX VENTURE: IPA) (OTCQB: IPATF), an industry leader in the discovery of novel, therapeutic antibo...
ImmunoPrecise Strengthens Board of Directors with Antibody Business Leader, Brian Lundstrom Canada NewsWire VICTORIA, Oct. 3, 2019 VICTORIA , Oct. 3, 2019 /CNW/ - IMMUNOPRECISE ANTIBODIES LTD. (the "Company" or "IPA") (TSX VENTURE: IPA) (OTC QB: IPATF) a provider of best-...
ImmunoPrecise Antibodies Appoints Biotech Industry Executive Dr. Stefan Lang as Chief Business Officer Canada NewsWire VICTORIA, Oct. 1, 2019 VICTORIA , Oct. 1, 2019 /CNW/ - IMMUNOPRECISE ANTIBODIES LTD. (the "Company" or "IPA") (TSX VENTURE: IPA) (OTCQB: IPATF) a pr...
ImmunoPrecise Antibodies ( OTCQB:IPATF ): Q1 GAAP EPS of -C$0.03. Revenue of C$2.71M (-5.6% Y/Y) Press Release More news on: ImmunoPrecise Antibodies Ltd., Earnings news and commentary, ,
ImmunoPrecise Antibodies Announces 95.7% Investors Favored Debenture Extension and Q1 2020 Financial Results Canada NewsWire VICTORIA, Sept. 30, 2019 VICTORIA , Sept. 30, 2019 /CNW/ - IMMUNOPRECISE ANTIBODIES LTD. (the "Company" or "IPA") (TSX VENTURE: IPA) (OTCQB: IPATF)...
ImmunoPrecise's Talem Therapeutics Enters into an LOI with AgonOx Pharma in the Advancement of Novel, Immuno-Oncology Therapeutics Canada NewsWire VICTORIA, Sept. 24, 2019 VICTORIA , Sept. 24, 2019 /CNW/ - IMMUNOPRECISE ANTIBODIES LTD. (the "Company" or "IPA") (TSX VENTUR...
ImmunoPrecise Launches Abthena™ Bispecific Platform And Artemis™ Intelligence Metadata (AIM) Canada NewsWire VICTORIA, Sept. 23, 2019 VICTORIA , Sept. 23, 2019 /CNW/ - IMMUNOPRECISE ANTIBODIES LTD. (the "Company" or "IPA") (TSX VENTURE: IPA) (OTCQB: IPATF), ...
ImmunoPrecise Antibodies ( OTCQB:IPATF ): FY GAAP EPS of -C$0.12. More news on: ImmunoPrecise Antibodies Ltd., Earnings news and commentary, , Read more ...
News, Short Squeeze, Breakout and More Instantly...
ImmunoPrecise Antibodies Ltd. Company Name:
IPATF Stock Symbol:
OTCMKTS Market:
ImmunoPrecise Antibodies to Begin Trading on Nasdaq Stock Exchange Canada NewsWire VICTORIA, BC , Dec. 23, 2020 /CNW/ - IMMUNOPRECISE ANTIBODIES LTD. (the "Company" or "IPA") (TSXV: IPA) (Nasdaq Global Markets: IPA), a leader in full-service, therapeu...
ImmunoPrecise Reports Financial Results and Recent Business Highlights for Second Quarter of 2021 Fiscal Year Canada NewsWire Record Quarterly Revenue of $4,754,545 and Adjusted EBITDA of $795,159 Announced Strategic Partnership ...
ImmunoPrecise and LiteVax Advance SARS-CoV-2 Vaccine Candidate VICTORIA, BC , Dec. 14, 2020 /PRNewswire/ - IMMUNOPRECISE ANTIBODIES LTD. ("IPA") (TSXV: IPA) (IPATD: IPA) (FSE: TQB), a leader in full-service, therapeutic antibody discovery and development and LiteVax...